PMID: 41962306

Patient-reported outcomes and qualitative interviews in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: results from the phase III EMBER-3 trial.

Curigliano G, O'Shaughnessy J, Bidard F-C, Casalnuovo M L, Kim S-B, Tokunaga E, Aftimos P, Saura C, Carey L A, Okera M

ESMO open · 2026

Vol. 11, Issue 4, pp. 106945

View on PubMedDOI

This entry links to third-party literature. For research use only.

HumansBreast NeoplasmsPatient Reported Outcome MeasuresFemaleMiddle AgedQuality of LifeErb-b2 Receptor Tyrosine KinasesAdultAgedEstrogen Receptor alpha

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.